Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300069449Phase 4Not yet recruiting
Phase 4, randomised trial in postoperative delirium (POD) comparing Remimazolam maintenance group with Propofol maintenance group (2 arms). Primary endpoint: Incidence of postoperative delirium. Planned start Nov 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300069449.